Logan Capital Management Inc. Sells 2,042 Shares of UnitedHealth Group Incorporated (NYSE:UNH)

Logan Capital Management Inc. lowered its position in UnitedHealth Group Incorporated (NYSE:UNH - Free Report) by 8.8% in the 4th quarter, according to the company in its most recent filing with the SEC. The fund owned 21,178 shares of the healthcare conglomerate's stock after selling 2,042 shares during the quarter. Logan Capital Management Inc.'s holdings in UnitedHealth Group were worth $10,713,000 as of its most recent SEC filing.

Several other large investors have also recently modified their holdings of UNH. NewSquare Capital LLC bought a new stake in UnitedHealth Group during the fourth quarter valued at $25,000. Marshall & Sterling Wealth Advisors Inc. purchased a new position in shares of UnitedHealth Group during the fourth quarter worth about $26,000. Hurley Capital LLC purchased a new stake in UnitedHealth Group in the fourth quarter valued at approximately $28,000. Aster Capital Management DIFC Ltd purchased a new position in UnitedHealth Group in the 4th quarter worth approximately $30,000. Finally, AlphaMark Advisors LLC purchased a new stake in shares of UnitedHealth Group during the 4th quarter valued at $30,000. Hedge funds and other institutional investors own 87.86% of the company's stock.

UnitedHealth Group Stock Down 17.8%

UnitedHealth Group stock traded down $67.52 during mid-day trading on Tuesday, reaching $311.23. The stock had a trading volume of 59,030,372 shares, compared to its average volume of 4,969,340. The company has a market capitalization of $282.33 billion, a price-to-earnings ratio of 20.08, a PEG ratio of 1.37 and a beta of 0.56. The company has a debt-to-equity ratio of 0.74, a current ratio of 0.83 and a quick ratio of 0.91. UnitedHealth Group Incorporated has a one year low of $309.10 and a one year high of $630.73. The company has a 50-day moving average price of $482.53 and a two-hundred day moving average price of $519.28.

UnitedHealth Group (NYSE:UNH - Get Free Report) last announced its quarterly earnings data on Thursday, April 17th. The healthcare conglomerate reported $7.20 earnings per share for the quarter, missing analysts' consensus estimates of $7.29 by ($0.09). UnitedHealth Group had a return on equity of 26.69% and a net margin of 3.60%. The firm had revenue of $109.58 billion during the quarter, compared to analysts' expectations of $111.56 billion. During the same quarter in the previous year, the firm earned $6.91 earnings per share. On average, analysts expect that UnitedHealth Group Incorporated will post 29.54 EPS for the current fiscal year.

UnitedHealth Group Dividend Announcement

The business also recently disclosed a quarterly dividend, which was paid on Tuesday, March 18th. Investors of record on Monday, March 10th were given a dividend of $2.10 per share. The ex-dividend date of this dividend was Monday, March 10th. This represents a $8.40 dividend on an annualized basis and a yield of 2.70%. UnitedHealth Group's dividend payout ratio (DPR) is 35.18%.

Wall Street Analyst Weigh In

A number of equities research analysts have weighed in on UNH shares. Barclays lowered their price target on UnitedHealth Group from $642.00 to $560.00 and set an "overweight" rating on the stock in a research report on Monday, April 21st. Argus downgraded UnitedHealth Group from a "buy" rating to a "hold" rating in a research report on Monday, April 21st. HSBC reissued a "hold" rating and set a $490.00 price target on shares of UnitedHealth Group in a research note on Tuesday, April 22nd. Erste Group Bank lowered shares of UnitedHealth Group from a "strong-buy" rating to a "hold" rating in a report on Wednesday, April 30th. Finally, Wells Fargo & Company reduced their price objective on UnitedHealth Group from $694.00 to $660.00 and set an "overweight" rating on the stock in a research note on Tuesday, January 28th. Four research analysts have rated the stock with a hold rating, nineteen have issued a buy rating and two have assigned a strong buy rating to the company. According to MarketBeat.com, the company presently has an average rating of "Moderate Buy" and an average price target of $596.86.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.